Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tirzepatide is an investigational dual incretin receptor agonist designed to activate two key receptor systems involved in metabolic regulation: GLP-1 receptor GIP receptor This receptor profile places Tirzepatide between Semaglutide and Retatrutide in mechanistic breadth
Some epidemiological data indicate potential associations with reduced rates of certain obesity-related malignancies, possibly related to weight loss and improved metabolic health, though causality has not been established
The brand's About page references approximately 14,000 patients
Conclusion 12
55, Aug
US$ 21.38
US$ 25.27
US$ 25.70
US$ 21.07
US$ 20.65
